Cormedix Affirms FY2026 Sales Guidance of $325.000M-$345.000M vs $337.061M Est
Benzinga Newsdesk 2 hours ago
NewsGuidance
Cormedix (NASDAQ:CRMD) affirms FY2026 sales outlook from $325.000 million-$345.000 million to $325.000 million-$345.000 million vs $337.061 million estimate.
Cormedix (NASDAQ:CRMD) affirms FY2026 sales outlook from $325.000 million-$345.000 million to $325.000 million-$345.000 million vs $337.061 million estimate.